Cargando…

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice

COVID-19 convalescent plasmas (CCPs) are chosen for plasma therapy based on neutralizing titers and anti-Spike immunoglobulin levels. However, CCP characteristics that promote SARS-CoV-2 control are complex and incompletely defined. Using an in vivo imaging approach, we demonstrate that CCPs with lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullah, Irfan, Beaudoin-Bussières, Guillaume, Symmes, Kelly, Cloutier, Marc, Ducas, Eric, Tauzin, Alexandra, Laumaea, Annemarie, Grunst, Michael W., Dionne, Katrina, Richard, Jonathan, Bégin, Philippe, Mothes, Walther, Kumar, Priti, Bazin, Renée, Finzi, Andrés, Uchil, Pradeep D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799175/ https://www.ncbi.nlm.nih.gov/pubmed/36584683 http://dx.doi.org/10.1016/j.xcrm.2022.100893

Ejemplares similares

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
por: Chen, Yaozong, et al.
Publicado: (2021)

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
por: Chen, Yaozong, et al.
Publicado: (2022)

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
por: Gasser, Romain, et al.
Publicado: (2021)

Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2’s evasive maneuvering
por: Grunst, Michael W., et al.
Publicado: (2022)

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2022)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
por: Tauzin, Alexandra, et al.
Publicado: (2021)

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020)

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
por: Ullah, Irfan, et al.
Publicado: (2021)

A Recent SARS-CoV-2 Infection Enhances Antibody-Dependent Cellular Cytotoxicity against Several Omicron Subvariants following a Fourth mRNA Vaccine Dose
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2023)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Effects of gp120 Inner Domain (ID2) Immunogen Doses on Elicitation of Anti-HIV-1 Functional Fc-Effector Response to C1/C2 (Cluster A) Epitopes in Mice
por: Sherburn, Rebekah, et al.
Publicado: (2020)

In vivo imaging of retrovirus infection reveals a role for Siglec-1/CD169 in multiple routes of transmission
por: Haugh, Kelsey A, et al.
Publicado: (2021)

HIV-1 Vpu restricts Fc-mediated effector functions in vivo
por: Prévost, Jérémie, et al.
Publicado: (2022)

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells
por: Ding, Shilei, et al.
Publicado: (2021)

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
por: Lu, Maolin, et al.
Publicado: (2020)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
por: Sherburn, Rebekah, et al.
Publicado: (2021)

VE607 stabilizes SARS-CoV-2 Spike in the “RBD-up” conformation and inhibits viral entry
por: Ding, Shilei, et al.
Publicado: (2022)

Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern
por: Li, Wenwei, et al.
Publicado: (2021)

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
por: Li, Wenwei, et al.
Publicado: (2022)

Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy
por: Amri, Nada, et al.
Publicado: (2022)

TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling
por: Lascano, Josefina, et al.
Publicado: (2015)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
por: Amri, Nada, et al.
Publicado: (2022)

RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION
por: Bazin, Renee, et al.
Publicado: (2023)

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2021)

HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes
por: Li, Wenwei, et al.
Publicado: (2023)

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
por: Bégin, Philippe, et al.
Publicado: (2022)

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
por: Tauzin, Alexandra, et al.
Publicado: (2022)

A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2021)

Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques
por: Tolbert, William D., et al.
Publicado: (2022)

TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle
por: Uchil, Pradeep D, et al.
Publicado: (2008)

Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site
por: Tolbert, William D., et al.
Publicado: (2020)

Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
por: Chen, Yaozong, et al.
Publicado: (2022)

Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
por: Tauzin, Alexandra, et al.
Publicado: (2023)

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
por: Chatterjee, Debashree, et al.
Publicado: (2022)

TRIM5alpha contributes to the anti-viral state
por: Pertel, Thomas, et al.
Publicado: (2009)

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
por: Chatterjee, Debashree, et al.
Publicado: (2022)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
por: Ventura, John D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2g434m9hbgprqrpj47220hscp1